This page includes the latest FDA filings for Bridgebio Pharma Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | BBIO | DUNS 117109644 |
Device Company | Device | Date |
---|---|---|
BridgeBio Pharma, Inc. | Prescription Medication | 2024-11-27 |
NCAGE Code | 8FVJ9 | BRIDGEBIO PHARMA, INC. |
CAGE Code | 8FVJ9 | BRIDGEBIO PHARMA, INC. |
SEC | 0001743881 | BridgeBio Pharma, Inc. of DELAWARE |